A therosclerosis is a chronic inflammatory process perpetuated by a variety of proinflammatory mediators, ie, cytokines and chemokines, during all stages of the disease, with myocardial infarction, stroke, or sudden cardiac death as fatal end points. Various lipid fractions, inflammatory cells, and fibrous elements accumulate in the vessel wall and determine progression of the disease. 1 In particular, LDL retained in the intima of a vessel undergoes oxidative modification and subsequently may enhance the expression of chemokines and proinflammatory cytokines, ie, that of interleukin (IL)-6. 2 Administration of supraphysiological concentrations of exogenous IL-6 in the murine apolipoprotein E-deficient (ApoE Ϫ/Ϫ ) model of atherosclerosis may enhance atherosclerotic lesion formation dramatically, suggesting a pivotal role for IL-6 in plaque progression. 3 However, the impact and role of physiological levels of endogenous IL-6 on atherosclerotic lesion formation remain unknown. In this regard, plasma levels of IL-6 are not only enhanced in patients with unstable angina but also predict the outcome of patients with acute coronary syndromes. 4 In contrast, the antiatherosclerotic cytokine IL-10 is reduced in patients with acute myocardial infarction and downregulates IL-6 in vivo and in vitro, 5, 6 suggesting that the balance of proinflammatory (IL-6) and antiinflammatory (IL-10) mediators may determine the perpetuation of atherogenesis.
Because IL-6 may also be a pivotal regulator of extracellular matrix deposition and reorganization 7, 8 (which may be important for atherosclerotic plaque progression and stability 9 ), we investigated whether a lifetime IL-6 deficiency could alter atherosclerotic lesion formation in the murine ApoE Ϫ/Ϫ model of atherosclerosis. Moreover, IL-6 is a cytokine with multiple and complex endocrine effects on lipid metabolism, 10 -12 and therefore, ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ double-knockout male mice were housed for 1 year while being maintained on a regular chow diet (instead of a cholesterol-enriched diet). ApoE Ϫ/Ϫ single-knockout mice (C57BL/6 background), IL-6 Ϫ/Ϫ single-knockout (C57BL/6 background), and C57BL/6 wild-type (WT) mice served as controls.
Here we report that a lifetime deficiency of IL-6 in the ApoE Ϫ/Ϫ model elicits opposing functions by enhancing atherosclerotic lesion formation and increasing serum cholesterol levels but by decreasing the accumulation of inflammatory cells in atherosclerotic plaque.
Methods

Animals
ApoE
Ϫ/Ϫ and C57BL/6 mice were obtained from Jackson Laboratories (Bar Harbor, Me). IL-6 Ϫ/Ϫ mice 13 were kindly provided by Prof Wienand and Dr Mossmann (Max-Planck-Institute for Immunobiology, Freiburg, Germany). Only male mice 53Ϯ4 weeks of age, fed a normal rodent diet (Altromin) and water ad libitum, were used for analyses.
Blood Pressure
Systolic blood pressure was measured by a noninvasive tail-cuff method with the BP-2000 blood pressure analysis system (Visitech Systems). All animals underwent repeated measurements on 3 different days 2 weeks before preparation.
Tissue Preparation for Collagen Measurement
Animals were humanely killed after the indicated observation period by intraperitoneal injection of ketamine/xylazine, and analyses were carried out according to previously published methods 14 -16 by polarized light microscopy.
Plaque Size
Mice were humanely killed by intraperitoneal injection of ketamine/ xylazine, and aortas were isolated. The adventitia was removed by enzymatic digestion (30 U/L collagenase, (Biochrom) and (12 L/mL elastase, Serva) in phosphate-buffered saline, pH 7.4, for 15 minutes at 37°C. The vessel was opened longitudinally and stained with oil red O (Merck). Sections were mounted on slides, and lesion size was quantified while being viewed under a stereomicroscope (Zeiss) coupled to a computerized morphometry system (Quantimet 500, Leica).
Immunohistochemical Analysis
Serial cryostat cross sections were incubated with the following primary antibodies: matrix metalloproteinase (MMP)-9, collagen I, collagen V, Mac3 for macrophages, and CD45 for leukocytes. The biotinylated secondary antibody was detected by a peroxidaseavidin-biotin-complex system (Vectastain, Vector Laboratories) and diaminobenzidine (Boehringer Mannheim).
Plasma Lipid and Lipoprotein Analyses
Plasma samples were obtained by retrobulbar puncture with heparinized capillary tubes after a 12-hour overnight fast, and lipoproteins were isolated from mouse plasma and determined as described previously. 17 
Reverse Transcriptase-Polymerase Chain Reaction
Aortic tissue was immediately shock-frozen in LN 2 .
Gelatin Zymography
Protein samples from aortic tissue were separated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis, supplemented with 1 mg/mL gelatin, as described by Grote et al. 8 Please refer to the online-only Data Supplement for details.
Results
WT, IL-6
Ϫ/Ϫ , ApoE Ϫ/Ϫ , and ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ double-knockout male mice were housed for 53Ϯ4 weeks while being maintained on a regular rodent chow diet. No differences with regard to survival, morbidity, or behavior were observed. Systolic blood pressure was not different between the strains (101Ϯ2 mm Hg in ApoE Ϫ/Ϫ , 106Ϯ1 mm Hg in ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ , 105Ϯ3 mm Hg in IL-6 Ϫ/Ϫ , and 102Ϯ2 mm Hg in WT mice). Aortic plaque extension was predominantly detected in the aortic arch; in branching of the subclavian, renal, and femoral arteries; and in the abdominal aorta, as described before. 18 Figure 1A shows representative aortic en face preparations from the 4 mouse strains; plaques were visualized in red (oil red O stain). ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ animals developed a greater number of and more extensive lesions, and random lipid deposits appeared throughout the entire aorta. Quantitative analysis of relative lesion area revealed significantly enhanced lesion formation in ApoE Ϫ/Ϫ and 0.1% in WT mice). Morphometric analysis of defined sections showed that lesion size was significantly increased in ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice ( Figure 1C , PϽ0.05). Serum lipids were determined in plasma samples after a 12-hour overnight fast ( Figure 2 ). ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ developed significantly higher levels of total cholesterol, LDL, and VLDL compared with ApoE Ϫ/Ϫ mice, whereas triglycerides were unaffected. Levels of total cholesterol, LDL, and VLDL were significantly higher in ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ and ApoE
animals compared with IL-6 Ϫ/Ϫ and WT mice because of the apoE knockout; the controls themselves did not differ. Because IL-6 levels may be regulated by IL-10, its synthesis and release were determined ( Figure 3 ). Both aortic IL-10 mRNA expression ( Figure 3A PϽ0 .01) and IL-10 serum levels were significantly reduced in ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice compared with ApoE Ϫ/Ϫ mice ( Figure 3B , PϽ0.01). In IL-6 Ϫ/Ϫ mice and WT controls, IL-10 transcripts were not detectable, and IL-10 plasma levels were significantly lower compared with those in ApoE Ϫ/Ϫ mice. Because IL-6 and IL-10 may modulate inflammatory cell maturation, differentiation, and recruitment, 19, 20 we determined the accumulation of inflammatory cells in atherosclerotic lesions of the aortic arch of the apoE-deficient strains with atherosclerosis. We observed a significant reduction of Mac3-and CD45-positive cells (PϽ0.01), representing macrophages and leukocytes within sections of ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice (Figure 4 ), although the plaque load was higher. In IL-6 Ϫ/Ϫ mice and WT controls, Mac3-and CD45-positive cells were only occasionally detectable and did not differ between the groups.
In aortic cross sections from ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ animals stained with Sirius red for total collagen content, we observed disintegration and alteration of extracellular matrix assembly within the medial and adventitial layers of the vessel wall ( Figure 5A ). Quantification of Sirius red-stained sections of the aortic arch revealed significantly reduced collagen content in plaques of ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice ( Figure 5B , PϽ0.05 versus ApoE Ϫ/Ϫ ). In IL-6 Ϫ/Ϫ and WT mice, plaques were too rare and too small to analyze. Similarly, gene expression levels (summarized in Figure 6 ) and immunohistochemical staining for collagen I and V ( Figure 5C ) revealed reduced synthesis of these collagens. In addition, MMP-9 mRNA levels ( Figure 6 , PϽ0.05 versus ApoE Ϫ/Ϫ ) and protein ( Figure  5D ), responsible for collagen I and V degradation, were significantly reduced in ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice. In contrast, the gelatinolytic activity of MMP-9 was significantly increased in the double-knockout mice ( Figure 5E , PϽ0.05 versus ApoE Ϫ/Ϫ ). This may be explained by a reduced tissue inhibitor of metalloproteinase (TIMP)-1 mRNA levels (Figure 6 , PϽ0.05), which negatively controls MMP-9 activity. MMP-9 activity was significantly lower in both controls.
Vascular development is also modulated by maturation of extracellular collagens and elastin. Lysyl oxidase controls this process, oxidizes peptidyl lysine within the collagen and elastin molecule, and thereby initiates formation of the covalent cross-linkages between molecules that insolubilize the extracellular matrix proteins. 21 In ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice, aortic mRNA levels of lysyl oxidase were reduced and not detectable in controls ( Figure 6 ).
Discussion
Here we report that a lifetime deficiency of IL-6 in the ApoE Ϫ/Ϫ model of atherosclerosis resulted in enhanced formation of atherosclerotic lesions, reduced collagen metabolism, and elevated levels of serum cholesterol. IL-6 deficiency blunted the synthesis and release of its counteracting cytokine IL-10 and suppressed the recruitment of proinflammatory cells into the atherosclerotic plaque. Therefore, we suggest that IL-6 elicits a dual modulatory role in atherosclerosis by reducing the lipid accumulation in atherosclerotic lesions and enhancing the recruitment of inflammatory cells to the atherosclerotic plaque, thus modulating vessel extracellular matrix assembly.
IL-6 has long been associated with unstable angina as a potential indicator of plaque destabilization, 4 but a direct link between IL-6 and plaque decomposition has never been shown. In vivo analysis revealed that IL-6 induces monocyte differentiation, MMP expression, and complement activation through acute-phase proteins that may affect the plaque's fibrous cap composition. 22 In vivo analysis further demonstrated that short-term administration of excessive amounts of exogenous IL-6 resulted in enhanced plaque development in young ApoE Ϫ/Ϫ mice, also owing to the upregulation of other proinflammatory modulators such as tumor necrosis factor-␣ and IL-1, especially with high-fatdiet feeding. 3 Together with the results that indicate that IL-6 is an important predictor of the recurrence of cardio- vascular events and observations that have demonstrated an association between IL-6 and acute-phase proteins in patients with unstable angina, 4 we hypothesized that a deficiency of IL-6 may reduce plaque formation in experimental atherosclerosis.
To test this hypothesis, we generated ApoE Ϫ/Ϫ -IL-6
Ϫ/Ϫ double-knockout mice. Unexpectedly, a lifetime deficiency of both IL-6 and apoE resulted in enhanced plaque formation, compared with the single apoE-knockout, raising the possibility that IL-6 is involved in basic (patho-)physiological regulatory mechanisms of cholesterol homeostasis and vessel development (ie, opposing effects for atherosclerosis). One mechanism may involve the downregulation of IL-10 in ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice, which is known to decrease serum cholesterol levels through an as-yet-unknown mechanism. 23 Thus, the expression and mutual regulation of IL-6 and IL-10 seem to reflect a crucial step not only in the modulation of inflammation but also in the regulation of cholesterol homeostasis. Depletion of IL-6 and IL-10, as observed in the present study, may increase serum cholesterol levels and subsequently enhance plaque formation, presuming a basal inflammation status in both ApoE Ϫ/Ϫ models, because we did not observe an effect due to IL-6 deficiency alone (IL-6 Ϫ/Ϫ compared with WT). IL-6 deficiency in ApoE Ϫ/Ϫ mice may also have a direct effect on cholesterol metabolism. In our study and in the absence of a cholesterol-rich diet, these mice had a proatherogenic lipoprotein profile with significantly enhanced plasma total cholesterol levels. IL-6 is a cytokine with multiple and complex endocrine effects on lipid metabolism: administration of IL-6 to nonhuman primates 10 and cancer patients 11 resulted in a decrease of total cholesterol levels, whereas in healthy volunteers, it caused a significant increase in total cholesterol. 24 In patients with myocardial infarction, 25 after major surgery, 26, 27 or on hemodialysis, 28 circulating IL-6 levels are correlated negatively with total cholesterol levels. Thus, the molecular and cellular mechanisms that elicit IL-6 effects on lipoprotein metabolism need further investigation. On the basis of current observations, we speculate that in ApoE Ϫ/Ϫ -IL-6
Ϫ/Ϫ mice, a defect in VLDL and LDL catabolism may exist.
Preliminary results indicate that the production rate of the apoB-containing lipoproteins VLDL and LDL is not altered in IL-6 -deficient animals compared with controls (U.J.F. Tietge, unpublished observations). Therefore, differences only emerge when the turnover rate of lipoproteins is decreased in genetic models like the ApoE Ϫ/Ϫ mice may show enhanced plaque formation, 12 we hardly observed any plaque formation in 1-yearold male IL-6 Ϫ/Ϫ mice being fed normal rodent chow. However, in the ApoE Ϫ/Ϫ model, IL-6 deficiency resulted in enhanced atherosclerosis and also provided evidence that IL-6 may be a major regulator of normal vessel development. Suppression of IL-10 synthesis and release in ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ double-knockout mice compared with ApoE Ϫ/Ϫ mice was associated with a decrease in recruited macrophages and leukocytes at the atherosclerotic lesion, suggesting a reduced inflammatory balance at the atherosclerotic plaque. A balanced interplay between proinflammatory and antiinflammatory mediators (IL-6 and IL-10) may be involved in the perpetuation of atherosclerosis within the vessel wall and may modulate the development of atherosclerotic plaques by recruiting inflammatory cells (Mac3-and CD45-positive) to the plaque. 29 This hypothesis is supported by the observation that in IL-6 Ϫ/Ϫ and WT animals without atherosclerotic plaques, IL-10 transcripts and protein levels were not different but were significantly lower than in both ApoE Ϫ/Ϫ knockout strains. Moreover, previous observations concerning IL-10 suggest that a baseline synthesis of IL-6 is required to maintain IL-10 homeostasis. 30 However, IL-10 synthesis and release are not completely blunted despite a lack of IL-6. This observation might be explained by the enhanced serum LDL concentration in the ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mouse model, which also stimulates IL-10 synthesis. 31 In addition, IL-6 could, at least in part, be functionally replaced by other cytokines of the IL-6 family, ie, oncostatin M or leukemia inhibitory factor, that signal through the same receptor component, gp130. 19 Thus, knocking out gp130 would enable us to study not only the proatherogenic effects of the IL-6 cytokine family but also that of the IL-6 -dependent acute-phase reaction.
In ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice, reduced concentrations of collagens I and V in aortic plaques were associated with a significantly higher gelatinolytic activity of MMP-9, although MMP-9 protein levels were also reduced. The latter may be explained either by a significantly reduced expression level of TIMP-1 in ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice or by enhanced cholesterol accumulation within the vessel wall, which may stimulate oxidative stress and thereby promote gelatinolytic MMP activity in vitro. 8 Thus, IL-6 deficiency may shift the equilibrium of TIMP-1 and MMP-9 toward a more unbalanced MMP activation, which has previously been described as a basic mechanism for organ development. 32 Sirius red staining showed a peculiar folding and disintegration of extracellular matrix within the media and adventitia, suggesting that MMP activity is not the only activity altered by IL-6 deficiency. In this regard, lysyl oxidase, required for collagen cross-linking and for the development of cardiovascular tissues, eg, myocardium and aorta, 33 is also decreased by IL-6 deficiency. However, lysyl oxidase was not detectable at the transcriptional level in WT and IL-6 Ϫ/Ϫ mice, because we analyzed only adult animals that showed no special vessel development or atherosclerosis. Moreover, hypercholesterolemia, as observed in ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice, downregulates lysyl oxidase 34 and subsequently may contribute to lesion formation. Thus, alteration of extracellular matrix assembly, which was observed in the present study, may represent a vascular developmental defect that is induced by a lifetime deficiency of IL-6.
In summary, we have demonstrated that a deficiency of IL-6 in the ApoE Ϫ/Ϫ model elicits Janus-like opposing functions by enhancing atherosclerotic lesion formation and increasing serum cholesterol levels but decreasing the accumulation of inflammatory cells at the atherosclerotic plaque. Together with a reduced synthesis and release of IL-10 in ApoE Ϫ/Ϫ -IL-6 Ϫ/Ϫ mice, these results are consistent with the notion that in the process of atherogenesis (in the presence of a hypercholesterolemia), the balance between IL-6 and IL-10 may be crucial for lipid homeostasis, plaque formation, and plaque morphology.
